Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort studyShun Kohsaka, Dianna J. Magliano, Matthias Saathoff et al.|The Lancet Diabetes & Endocrinology|2020Cited by 93
Trends of polypharmacy among older people in Asia, Australia and the United Kingdom: a multinational population-based studyHyesung Lee, Ju‐Young Shin, Yeon‐Hee Baek et al.|Age and Ageing|2023Cited by 32
Application of Healthcare ‘Big Data’ in CNS Drug Research: The Example of the Neurological and mental health Global Epidemiology Network (NeuroGEN)Jenni Ilomäki, Ian Chi Kei Wong, J. Simon Bell et al.|CNS Drugs|2020Cited by 28
Cross-Regional Data Initiative for the Assessment and Development of Treatment for Neurological and Mental DisordersDaniel Hsiang‐Te Tsai, Edward Chia‐Cheng Lai, J. Simon Bell et al.|Clinical Epidemiology|2023Cited by 16